Live tape
Top 8, mentions 7d6,899GOOGL1,551 mentions▲ +0.03NKE1,369 mentions▲ +0.03META1,009 mentions▲ +0.05NVDA881 mentions▲ +0.09TSLA603 mentions▲ +0.05MSFT503 mentions▲ +0.04AMZN493 mentions▲ +0.06AAPL490 mentions▲ +0.06

Equity · Healthcare

GMAB

NASDAQ

Genmab A/S

$28.71 −1.02% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Jul 17, 2026
Price · Chart
Our own end-of-day closes 10 sessions
$31 $28 6 Jul 17 Jul

The line runs $28.01 on 6 July through $28.71 on 17 July, on a scale from $28 to $31. Days the market did not trade hold the previous close, flat.

The chart above plots the price of GMAB over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 10 sessions over that window: $28.01 on 6 July 2026 through $28.71 on 17 July 2026.

52-week range $21.08 – $35
Avg volume 642.2K

Finazon · prior-day close, indicative (IEX-derived, not the official close) · as of Jul 17, 2026

Filings 4 sets

GMAB reported financials

SEC EDGAR XBRL

GMAB reported revenue of $3.7B for the fiscal year ended 31 Dec 2025. Net income over the same period was $963.0M.

Figure Reported Period
Revenue $3.7B 31 Dec 2025 fiscal year
Net income $963.0M 31 Dec 2025 fiscal year
Diluted earnings loss per share $15.37 31 Dec 2025 fiscal year
Total assets $12.9B 31 Dec 2025 at period end
Equity $5.8B 31 Dec 2025 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 31 Dec 2025

GMAB institutional holders

SEC Form 13F

7 of the 45 institutional funds we track reported a GMAB position for the quarter ended 30 Jun 2026 — a combined $315.4M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Renaissance Technologies Held (±25%) −20.3% shares 3,517,850 $96.6M
Two Sigma Investments Added +49.9% shares 3,506,843 $96.3M
Citadel Advisors New position 2,475,991 $68.0M
Millennium Management Held (±25%) +14.9% shares 910,604 $25.0M
Marshall Wace Added +5,431.1% shares 829,659 $22.8M
Point72 Asset Management New position 135,647 $3.7M
AQR Capital Management Added +27.4% shares 106,104 $2.9M

Source: SEC EDGAR 13F filings

GMAB fails-to-deliver

SEC CNS data

On 09 Sep 2026, 4,958 shares of GMAB failed to deliver (about $166K).

Settlement date Shares failed Notional
09 Sep 2026 4,958 $166K
02 Sep 2026 6,233 $207K
28 Aug 2026 197 $7K
26 Aug 2026 857 $29K
20 Aug 2026 32,527 $1.1M
18 Aug 2026 388 $13K

Source: SEC fails-to-deliver (CNS) data

Congressional trades in GMAB

STOCK Act disclosures

The most recent congressional trade disclosed in GMAB is a purchase by Josh Gottheimer (house, NJ), dated 16 Jan 2025.

Date Member Type Amount
16 Jan 2025 filed 10 Feb 2025 Josh Gottheimer house · Democrat–NJ Purchase $1K–$15K
16 Dec 2024 filed 14 Jan 2025 Josh Gottheimer house · Democrat–NJ Sale $1K–$15K
19 Jul 2024 filed 15 Aug 2024 Josh Gottheimer house · Democrat–NJ Purchase $1K–$15K
18 Jun 2024 filed 09 Jul 2024 Josh Gottheimer house · Democrat–NJ Sale $1K–$15K
16 Oct 2023 filed 11 Nov 2023 Josh Gottheimer house · Democrat–NJ Purchase $1K–$15K
15 Sep 2023 filed 15 Oct 2023 Josh Gottheimer house · Democrat–NJ Sale $1K–$15K
20 Jul 2023 filed 21 Aug 2023 Josh Gottheimer house · Democrat–NJ Purchase $1K–$15K
19 Jul 2023 filed 21 Aug 2023 Josh Gottheimer house · Democrat–NJ Purchase $1K–$15K

Source: U.S. House of Representatives financial disclosures